Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

AlloVir Stock

allovir.comHealthcareFunding to Date: $154.35MM

AlloVir is a biotechnology specializing in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Learn more about AlloVir IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for AlloVir.

Register Today

Team

Management Team

Ann Leen Ph.D

Chief Scientific Officer & Co-Founder

Juan Vera MD

Co-Founder, Chief Product Development Officer & Board Member

Cliona Rooney Ph.D

Advisor

David Hallal

Chief Executive Officer & Chairman

Helen Heslop MD

Co-Founder & Advisor

Elizabeth Stoner MD

Senior Clinical Advisor

Vikas Sinha

President, Chief Financial Officer & Board Member

Mitchell Finer Ph.D

Advisor

Board Members

John Wilson

Morana Jovan-Embiricos

David Hallal

Malcolm Brenner MD

Ansbert Gadicke

Juan Vera MD

Vikas Sinha

Other companies like AlloVir in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions